6151 - 6200 of 6230 Results
Title
Year
-
OPENTitle: Distinct Roles for RAB10 and RAB29 in Pathogenic LRRK2-Mediated Endolysosomal Trafficking AlterationsJournal Name: CellsPublisher: MDPI AGVol: 9Issue #: 7Start Page: 1719End Page: 1719Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells9071719Best OA location URL: https://www.mdpi.com/2073-4409/9/7/1719/pdf?version=1595002890Citation Count: 30
-
OPENTitle: Altered ceramide metabolism is a feature in the extracellular vesicle-mediated spread of alpha-synuclein in Lewy body disordersJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 142Issue #: 6Start Page: 961End Page: 984Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-021-02367-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-021-02367-3.pdfCitation Count: 45
-
OPENTitle: DeepSleep convolutional neural network allows accurate and fast detection of sleep arousalJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s42003-020-01542-8Best OA location URL: https://www.nature.com/articles/s42003-020-01542-8.pdfCitation Count: 39
-
OPENTitle: A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2Journal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 300Issue #: 7Start Page: 107469End Page: 107469Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.jbc.2024.107469Best OA location URL: https://doi.org/10.1016/j.jbc.2024.107469Citation Count: 1
-
OPENTitle: Voltage-Gated Proton Channel Hv1 Regulates Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson’s Disease ModelsJournal Name: AntioxidantsPublisher: MDPI AGVol: 12Issue #: 3Start Page: 582End Page: 582Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/antiox12030582Best OA location URL: https://www.mdpi.com/2076-3921/12/3/582/pdf?version=1677573522Citation Count: 6
-
OPENTitle: Increased D1 dopamine receptor signaling in levodopa‐induced dyskinesiaJournal Name: Annals of NeurologyPublisher: WileyVol: 57Issue #: 1Start Page: 17End Page: 26Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.20296Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.20296Citation Count: 388
-
OPENTitle: High-resolution local field potentials measured with deep brain stimulation arraysJournal Name: Journal of Neural EngineeringPublisher: IOP PublishingVol: 15Issue #: 4Start Page: 046019End Page: 046019Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1088/1741-2552/aabdf5Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6021212Citation Count: 16
-
OPENTitle: Improved motor outcome prediction in Parkinson's disease applying deep learning to DaTscan SPECT imagesJournal Name: Computers in Biology and MedicinePublisher: Elsevier BVVol: 132Issue #:Start Page: 104312End Page: 104312Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.compbiomed.2021.104312Best OA location URL: https://doi.org/10.1016/j.compbiomed.2021.104312Citation Count: 30
-
OPENTitle: Hydrop enables droplet-based single-cell ATAC-seq and single-cell RNA-seq using dissolvable hydrogel beadsJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.7554/elife.73971Best OA location URL: https://cdn.elifesciences.org/articles/73971/elife-73971-v5.pdfCitation Count: 56
-
OPENTitle: STEP61is a substrate of the E3 ligase parkin and is upregulated in Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 112Issue #: 4Start Page: 1202End Page: 1207Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1417423112Best OA location URL: https://www.pnas.org/content/pnas/112/4/1202.full.pdfCitation Count: 59
-
OPENTitle: Externally validated deep learning model to identify prodromal Parkinson’s disease from electrocardiogramJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-023-38782-7Best OA location URL: https://escholarship.org/content/qt8967r7rb/qt8967r7rb.pdfCitation Count: 10
-
OPENTitle: Varying the rate of intravenous cocaine infusion influences the temporal dynamics of both drug and dopamine concentrations in the striatumJournal Name: European Journal of NeurosciencePublisher: WileyVol: 50Issue #: 3Start Page: 2054End Page: 2064Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ejn.13941Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ejn.13941Citation Count: 20
-
OPENTitle: The MDS−UPDRS tracks motor and non-motor improvement due to subthalamic nucleus deep brain stimulation in Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 19Issue #: 11Start Page: 966End Page: 969Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2013.06.010Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3825788Citation Count: 73
-
OPENTitle: Parkinson’S Disease is Ready for Precision MedicineJournal Name: Personalized MedicinePublisher: Informa UK LimitedVol: 13Issue #: 5Start Page: 405End Page: 407Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2217/pme-2016-0052Best OA location URL: https://www.futuremedicine.com/doi/pdf/10.2217/pme-2016-0052Citation Count: 7
-
OPENTitle: Multimodal assessment of nigrosomal degeneration in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 80Issue #:Start Page: 102End Page: 107Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.09.021Best OA location URL: https://arxiv.org/pdf/2009.01378Citation Count: 17
-
OPENTitle: A Possible Novel Anti-Inflammatory Mechanism for the Pharmacological Prolyl Hydroxylase Inhibitor 3,4-Dihydroxybenzoate: Implications for Use as a Therapeutic for Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 12Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/364684Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/364684.pdfCitation Count: 17
-
OPENTitle: Valosin-containing-protein pathogenic variant p.R487H in Parkinson’s diseaseJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 10Issue #:Start Page: 100236End Page: 100236Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2024.100236Best OA location URL: https://doi.org/10.1016/j.prdoa.2024.100236Citation Count: 0
-
OPENTitle: Red hair, MC1R variants, and risk for Parkinson's disease – a meta‐analysisJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 4Issue #: 3Start Page: 212End Page: 216Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.381Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.381Citation Count: 26
-
OPENTitle: Improving patient‐centred care for persons with Parkinson's: Qualitative interviews with care partners about their engagement in discussions of “off” periodsJournal Name: Health ExpectationsPublisher: WileyVol: 22Issue #: 3Start Page: 555End Page: 564Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/hex.12884Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/hex.12884Citation Count: 20
-
OPENTitle: Network connectivity and local transcriptomic vulnerability underpin cortical atrophy progression in Parkinson’s diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 40Issue #:Start Page: 103523End Page: 103523Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2023.103523Best OA location URL: https://doi.org/10.1016/j.nicl.2023.103523Citation Count: 14
-
OPENTitle: Targeting β-arrestin2 in the treatment ofl-DOPA–induced dyskinesia in Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 112Issue #: 19Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1502740112Best OA location URL: https://www.pnas.org/content/pnas/112/19/E2517.full.pdfCitation Count: 97
- A Failed Future2020OPENTitle: A Failed FutureJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 8Start Page: 1299End Page: 1301Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28130Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28130Citation Count: 4
-
OPENTitle: A comparative study of Lrrk2 function in primary neuronal culturesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 16Issue #: 10Start Page: 650End Page: 655Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2010.08.018Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3159957Citation Count: 81
-
OPENTitle: LRRK2 maintains mitochondrial homeostasis and regulates innate immune responses to Mycobacterium tuberculosisJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.51071Best OA location URL: https://cdn.elifesciences.org/articles/51071/elife-51071-v2.pdfCitation Count: 104
-
OPENTitle: Low‐variance RNAs identify Parkinson's disease molecular signature in bloodJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 6Start Page: 813End Page: 821Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26205Best OA location URL: http://doi.org/10.1002/mds.26205Citation Count: 18
-
OPENTitle: Scaling of an antibody validation procedure enables quantification of antibody performance in major research applicationsJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.91645Best OA location URL: https://cdn.elifesciences.org/articles/91645/elife-91645-v2.pdfCitation Count: 43
-
OPENTitle: Synaptic Density and Glucose Consumption in Patients with Lewy Body Diseases: An [11C]UCB‐J and [18F]FDG PET StudyJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 5Start Page: 796End Page: 805Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29375Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29375Citation Count: 19
-
OPENTitle: Pharmacological Mechanism of the Non-hallucinogenic 5-HT2A Agonist Ariadne and AnalogsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 14Issue #: 1Start Page: 119End Page: 135Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.2c00597Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10147382Citation Count: 46
-
OPENTitle: NeuroBooster Array: A Genome‐Wide Genotyping Platform to Study Neurological Disorders Across Diverse PopulationsJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 11Start Page: 2039End Page: 2048Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.29902Best OA location URL: https://doi.org/10.1002/mds.29902Citation Count: 16
-
OPENTitle: Pharmacological validation of TDO as a target for Parkinson’s diseaseJournal Name: The FEBS JournalPublisher: WileyVol: 288Issue #: 14Start Page: 4311End Page: 4331Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/febs.15721Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/febs.15721Citation Count: 22
-
OPENTitle: A highly efficient, scalable pipeline for fixed feature extraction from large-scale high-content imaging screensJournal Name: iSciencePublisher: Elsevier BVVol: 27Issue #: 12Start Page: 111434End Page: 111434Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1016/j.isci.2024.111434Best OA location URL: https://doi.org/10.1016/j.isci.2024.111434Citation Count: 0
- Serum MicroRNAs Predict Isolated Rapid Eye Movement Sleep Behavior Disorder and Lewy Body Diseases2022OPENTitle: Serum MicroRNAs Predict Isolated Rapid Eye Movement Sleep Behavior Disorder and Lewy Body DiseasesJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 10Start Page: 2086End Page: 2098Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29171Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29171Citation Count: 18
-
OPENTitle: Cargo and cell‐specific differences in extracellular vesicle populations identified by multiplexed immunofluorescent analysisJournal Name: Journal of Extracellular VesiclesPublisher: WileyVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1080/20013078.2020.1789326Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1080/20013078.2020.1789326Citation Count: 32
-
OPENTitle: Increasing Efficiency of Recruitment in Early Parkinson’s Disease Trials: A Case Study Examination of the STEADY-PD III TrialJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 7Issue #: 4Start Page: 685End Page: 693Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-171199Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd171199?id=journal-of-parkinsons-disease%2Fjpd171199Citation Count: 20
-
OPENTitle: Executive functioning and risk-taking behavior in Parkinson’s disease patients with impulse control disordersJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 123Issue #: 6Start Page: 573End Page: 581Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00702-016-1549-yBest OA location URL: https://hal.sorbonne-universite.fr/hal-01311564v1/file/Pineau_2016_Executive.pdfCitation Count: 15
-
OPENTitle: Mutations in Parkinsonism-linked endocytic proteins synaptojanin1 and auxilin have synergistic effects on dopaminergic axonal pathologyJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00465-5Best OA location URL: https://www.nature.com/articles/s41531-023-00465-5.pdfCitation Count: 17
-
OPENTitle: USP30 sets a trigger threshold for PINK1–PARKIN amplification of mitochondrial ubiquitylationJournal Name: Life Science AlliancePublisher: Life Science Alliance, LLCVol: 3Issue #: 8Start Page: e202000768End Page: e202000768Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.26508/lsa.202000768Best OA location URL: https://www.life-science-alliance.org/content/lsa/3/8/e202000768.full.pdfCitation Count: 105
-
OPENTitle: Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson’s diseaseJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 147Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-024-02706-0Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-024-02706-0.pdfCitation Count: 39
-
OPENTitle: Biomonitorization of iron accumulation in the substantia nigra from Lewy body disease patientsJournal Name: Toxicology ReportsPublisher: Elsevier BVVol: 4Issue #:Start Page: 188End Page: 193Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.toxrep.2017.03.005Best OA location URL: https://ars.els-cdn.com/content/image/1-s2.0-S221475001730015X-fx1_lrg.jpgCitation Count: 25
-
OPENTitle: Epidemiology meets toxicogenomics: Mining toxicologic evidence in support of an untargeted analysis of pesticides exposure and Parkinson’s diseaseJournal Name: Environment InternationalPublisher: Elsevier BVVol: 170Issue #:Start Page: 107613End Page: 107613Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.envint.2022.107613Best OA location URL: https://doi.org/10.1016/j.envint.2022.107613Citation Count: 13
-
OPENTitle: A History of Senile Plaques: From Alzheimer to Amyloid ImagingJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 81Issue #: 6Start Page: 387End Page: 413Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/jnen/nlac030Best OA location URL: https://academic.oup.com/jnen/article-pdf/81/6/387/43778548/nlac030.pdfCitation Count: 26
-
OPENTitle: Bioactivity of AAV2‐neurturin gene therapy (CERE‐120): Differences between Parkinson's disease and nonhuman primate brainsJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 1Start Page: 27End Page: 36Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23442Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6333467Citation Count: 167
-
OPENTitle: CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 21Issue #: 3Start Page: 271End Page: 276Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.12.027Best OA location URL: http://doi.org/10.1016/j.parkreldis.2014.12.027Citation Count: 90
-
OPENTitle: Membrane association but not identity is required for LRRK2 activation and phosphorylation of Rab GTPasesJournal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 218Issue #: 12Start Page: 4157End Page: 4170Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1083/jcb.201902184Best OA location URL: https://rupress.org/jcb/article-pdf/218/12/4157/1395522/jcb_201902184.pdfCitation Count: 102
-
OPENTitle: Arm swing as a potential new prodromal marker of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 10Start Page: 1527End Page: 1534Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26720Best OA location URL: http://doi.org/10.1002/mds.26720Citation Count: 163
-
OPENTitle: Plasma-borne indicators of inflammasome activity in Parkinson’s disease patientsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-020-00147-6Best OA location URL: https://www.nature.com/articles/s41531-020-00147-6.pdfCitation Count: 65
-
OPENTitle: Genome Sequences of Novel Torque Teno Viruses Identified in Human Brain TissueJournal Name: Microbiology Resource AnnouncementsPublisher: American Society for MicrobiologyVol: 9Issue #: 37Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1128/mra.00924-20Best OA location URL: https://journals.asm.org/doi/pdf/10.1128/MRA.00924-20Citation Count: 4
-
OPENTitle: Non-exercise physical activity attenuates motor symptoms in Parkinson disease independent from nigrostriatal degenerationJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 21Issue #: 10Start Page: 1227End Page: 1231Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.08.027Best OA location URL: http://doi.org/10.1016/j.parkreldis.2015.08.027Citation Count: 23
-
OPENTitle: Nanorod-associated plasmonic circular dichroism monitors the handedness and composition of α-synuclein fibrils from Parkinson's disease models and post-mortem brainJournal Name: NanoscalePublisher: Royal Society of Chemistry (RSC)Vol: 16Issue #: 40Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1039/d4nr03002hBest OA location URL: https://doi.org/10.1039/d4nr03002hCitation Count: 0
-
OPENTitle: The effects of mood and cognition on daily functioning and quality of life in older people living with HIV and people with Parkinson’s disease.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 35Issue #: 7Start Page: 691End Page: 705Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1037/neu0000760Best OA location URL: http://psycnet.apa.org/journals/neu/35/7/691.pdfCitation Count: 2